Download Hospitals Insurance Coverage and Processing 
Pharmacy Times
JULY 16, 2025
Importantly, ACIP’s recommendations do have a strong influence, if not a mandate, on health insurance companies with respect to coverage and co-payments for immunizations as well as the Vaccines for Children Program, which provides coverage for access to vaccines for those who are 18 years or younger.
Pharmaceutical Technology
JULY 23, 2025
Find out more Introduced by the Medicines and Healthcare products Regulatory Agency (MHRA), it will allow patients to receive personalised treatments made at their hospital, clinic or near their homes. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. You will receive an email shortly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
AUGUST 14, 2025
Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Please check your inbox to download the Whitepaper. The undisclosed biotech company’s option agreement with Apertura will investigate the potential of TfR1 CapX in conjunction with its payloads aimed at treating CNS disorders.
Pharmacy Times
AUGUST 11, 2025
Transitions of care, or the movement of patients between health care settings or providers, impose a significant cost on the health care system due to frequent adverse events and hospital readmissions. 2 Although various programs aim to mitigate these risks, pharmacist-driven initiatives have proven particularly effective.
Pharmacy Times
JULY 22, 2025
These third-party administrators act as intermediaries between drug manufacturers, pharmacies, and insurance companies. PBMs negotiate prices, establish formularies, and process claims, while also creating preferred networks of pharmacies. Additionally, the role of pharmacy benefit managers (PBMs) cannot be overlooked.
Pharmaceutical Technology
JUNE 23, 2025
Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Please check your inbox to download the Whitepaper. In 2024, Otsuka announced the acquisition of US-based Jnana Therapeutics in a deal worth up to $1.1bn. Topic sponsors are not involved in the creation of editorial content.
Pharmaceutical Technology
JULY 30, 2025
By incorporating a cell line from AvenCell into good manufacturing practice processes, ViroCell met the challenge of delivering a high-yield vector within the required timeframe. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Please check your inbox to download the Whitepaper.
Expert insights. Personalized for you.
Let's personalize your content